project id: TCGA-LGG; case submitter id: TCGA-P5-A5F4; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.81; concentration: 0.15; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.33; rna integrity number: 7.6; age at index: 35; days to birth: -12851; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1977; age at diagnosis: 12851; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 231.0; icd 10 code: C71.0; last known disease status: not reported; morphology: 9451/3; primary diagnosis: Oligodendroglioma, anaplastic; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cerebrum; synchronous malignancy: No; tissue or organ of origin: Cerebrum; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 37; initial weight: 700.0; sample id: 9c174af7-ea73-413f-ab7d-b3bba7f4ac6c; sample submitter id: TCGA-P5-A5F4-01A; portion id: f67099c0-4f6f-45a2-82d7-b710130ae4e7; portion submitter id: TCGA-P5-A5F4-01A-11; slide id: eccbfa45-e2bc-4d8f-90d1-1ed7dbfe1f18; slide submitter id: TCGA-P5-A5F4-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 60.0; percent tumor cells: 30.0; percent tumor nuclei: 80.0; section location: TOP;